Your browser doesn't support javascript.
loading
The association of FKBP5 polymorphisms with the severity of depressive disorder in patients with methamphetamine use disorders.
Fang, Ting; Liu, Meng-Nan; Tian, Xiao-Yu; Lu, Guan-Yi; Li, Fei; Zhang, Xiaojie; Liu, Feng; Hao, Wei; Wu, Ning; Li, Hong; Li, Jin.
Afiliação
  • Fang T; State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Key Laboratory of Neuropsychopharmacology, Beijing Institute of Pharmacology and Toxicology, Beijing, China.
  • Liu MN; State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Key Laboratory of Neuropsychopharmacology, Beijing Institute of Pharmacology and Toxicology, Beijing, China.
  • Tian XY; State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Key Laboratory of Neuropsychopharmacology, Beijing Institute of Pharmacology and Toxicology, Beijing, China.
  • Lu GY; Medical School of Chinese PLA, Beijing, China.
  • Li F; State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Key Laboratory of Neuropsychopharmacology, Beijing Institute of Pharmacology and Toxicology, Beijing, China.
  • Zhang X; State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Key Laboratory of Neuropsychopharmacology, Beijing Institute of Pharmacology and Toxicology, Beijing, China.
  • Liu F; Department of Psychiatry, National Clinical Research Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Hao W; Compulsory Detoxification Center of Changsha Public Security Bureau, Changsha, Hunan, China.
  • Wu N; Department of Psychiatry, National Clinical Research Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Li H; State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Key Laboratory of Neuropsychopharmacology, Beijing Institute of Pharmacology and Toxicology, Beijing, China.
  • Li J; State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Key Laboratory of Neuropsychopharmacology, Beijing Institute of Pharmacology and Toxicology, Beijing, China.
Front Psychiatry ; 14: 1147060, 2023.
Article em En | MEDLINE | ID: mdl-37051166

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Psychiatry Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Psychiatry Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China